Prospan by Helixia
Natural health product licensed in Canada
- Other names
- Helixia Cough Effervescent Tablets, Prospan by Helixia Cough Effervescent Tablets, Prospan by Helixia Cough Relief Effervescent Tabs, Prospan by Helixia Cough Relief On-the-Go, Prospan by Helixia Cough Sparkling
- Licence holder
- PendoPharm, Division of/de Pharmascience Inc.
- NPN or DIN-HM
- 80129612
- Status
- Active licence
- Licence date
- 16 February 2024
- Revision date
- 28 August 2024
- Form
- Comprimé, effervescent
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hedera helix Extract : Matériel brut sec Extraction ratio : 5-7.5:1 Dry plant equivalent : 325-487.5 mg | 65 mg | Not calculated |
Non-medicinal ingredients
Saccharinate de sodium, Citrate de sodium dihydraté, Mannitol, Sorbitol, Hydrogénocarbonate de sodium, Carbonate de sodium anhydre, NA, Siméthicone, Hydroxystéarate de macrogolglycérol, Saveur d'orange sanguine, Cyclamate de sodium, Triglycérides à chaîne moyenne
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 12 years | 0.5 Comprimé | 3 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 11 years | 0.5 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used as an expectorant to help relieve coughs. Helps to support/improve respiratory function in patients with chronic bronchitis. Helps to relieve coughs and helps expectoration (loosens mucus) in patients with chronic bronchitis. Used as an expectorant to help relieve symptoms associated with chronic bronchitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80129612
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging